Outcomes of second-line treatment in chronic lymphocytic leukemia – a population-based study from a well defined geographical region between 2003 and 2013.

The article focuses on a non-randomized, uncontrolled, observational, retrospective study of patients diagnosed with chronic lymphocytic leukemia (CLL) between January 1, 2003 and December 31, 2012. The study attempts to determine the efficacy and safety of second-line therapies used in CLL patients in routine clinical care.